BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23434591)

  • 1. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.
    Zhou Y; Huang X; Hecker L; Kurundkar D; Kurundkar A; Liu H; Jin TH; Desai L; Bernard K; Thannickal VJ
    J Clin Invest; 2013 Mar; 123(3):1096-108. PubMed ID: 23434591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix stiffness-induced myofibroblast differentiation is mediated by intrinsic mechanotransduction.
    Huang X; Yang N; Fiore VF; Barker TH; Sun Y; Morris SW; Ding Q; Thannickal VJ; Zhou Y
    Am J Respir Cell Mol Biol; 2012 Sep; 47(3):340-8. PubMed ID: 22461426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.
    Sandbo N; Lau A; Kach J; Ngam C; Yau D; Dulin NO
    Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L656-66. PubMed ID: 21856814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Rho-Associated Coiled-Coil Forming Kinase Isoforms in Regulation of Stiffness-Induced Myofibroblast Differentiation in Lung Fibrosis.
    Htwe SS; Cha BH; Yue K; Khademhosseini A; Knox AJ; Ghaemmaghami AM
    Am J Respir Cell Mol Biol; 2017 Jun; 56(6):772-783. PubMed ID: 28225294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tensin 1 Is Essential for Myofibroblast Differentiation and Extracellular Matrix Formation.
    Bernau K; Torr EE; Evans MD; Aoki JK; Ngam CR; Sandbo N
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):465-476. PubMed ID: 28005397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms.
    Scharenberg MA; Pippenger BE; Sack R; Zingg D; Ferralli J; Schenk S; Martin I; Chiquet-Ehrismann R
    J Cell Sci; 2014 Mar; 127(Pt 5):1079-91. PubMed ID: 24424023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Rho-associated kinases suppresses cardiac myofibroblast function in engineered connective and heart muscle tissues.
    Santos GL; Hartmann S; Zimmermann WH; Ridley A; Lutz S
    J Mol Cell Cardiol; 2019 Sep; 134():13-28. PubMed ID: 31233754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanosensing by the α6-integrin confers an invasive fibroblast phenotype and mediates lung fibrosis.
    Chen H; Qu J; Huang X; Kurundkar A; Zhu L; Yang N; Venado A; Ding Q; Liu G; Antony VB; Thannickal VJ; Zhou Y
    Nat Commun; 2016 Aug; 7():12564. PubMed ID: 27535718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Purα/Purβ single-strand DNA-binding proteins attenuate smooth-muscle actin gene transactivation in myofibroblasts.
    Hariharan S; Kelm RJ; Strauch AR
    J Cell Physiol; 2014 Sep; 229(9):1256-71. PubMed ID: 24446247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblasts.
    Johnson LA; Rodansky ES; Haak AJ; Larsen SD; Neubig RR; Higgins PD
    Inflamm Bowel Dis; 2014 Jan; 20(1):154-65. PubMed ID: 24280883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice.
    Rahaman SO; Grove LM; Paruchuri S; Southern BD; Abraham S; Niese KA; Scheraga RG; Ghosh S; Thodeti CK; Zhang DX; Moran MM; Schilling WP; Tschumperlin DJ; Olman MA
    J Clin Invest; 2014 Dec; 124(12):5225-38. PubMed ID: 25365224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.
    Kurita Y; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Tsubouchi K; Sato N; Yoshida M; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
    Respir Res; 2017 Jun; 18(1):114. PubMed ID: 28577568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice.
    Jiang C; Huang H; Liu J; Wang Y; Lu Z; Xu Z
    Int J Mol Sci; 2012; 13(7):8293-8307. PubMed ID: 22942703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
    Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
    Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
    Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
    Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myofibroblasts exhibit enhanced fibronectin assembly that is intrinsic to their contractile phenotype.
    Torr EE; Ngam CR; Bernau K; Tomasini-Johansson B; Acton B; Sandbo N
    J Biol Chem; 2015 Mar; 290(11):6951-61. PubMed ID: 25627685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis.
    Knipe RS; Nurunnabi M; Probst CK; Spinney JJ; Abe E; Bose RJC; Ha K; Logue A; Nguyen T; Servis R; Drummond M; Haring A; Brazee PL; Medoff BD; McCarthy JR
    Am J Physiol Lung Cell Mol Physiol; 2023 Feb; 324(2):L190-L198. PubMed ID: 36625494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2.
    Sandbo N; Ngam C; Torr E; Kregel S; Kach J; Dulin N
    J Biol Chem; 2013 May; 288(22):15466-73. PubMed ID: 23580645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2/3 phosphorylation.
    Bei Y; Hua-Huy T; Duong-Quy S; Nguyen VH; Chen W; Nicco C; Batteux F; Dinh-Xuan AT
    Pulm Pharmacol Ther; 2013 Dec; 26(6):635-43. PubMed ID: 23928001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.